Bharat Biotech’s Covaxin to be evaluated as COVID-19 vaccine candidate in US

New Delhi, Feb 19: Hyderabad-based Bharat Biotech said its COVID-19 vaccine Covaxin will be evaluated as a vaccine candidate for the disease in the United States, the company on Saturday said in a statement. “Ocugen, Inc (NASDAQ: OCGN) announced that

Source: India News, India Breaking News, Latest news headlines in India – Oneindia News